Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03519997
Recruitment Status : Recruiting
First Posted : May 9, 2018
Last Update Posted : September 9, 2019
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 1, 2020
Estimated Study Completion Date : April 1, 2021